Over the past 10 years there has been an evolution in treatment options for rare disease patients. Cell & Gene therapies have given hope and now provide a therapeutic solution to treat & cure disease. Birthed from the World Orphan Drug Congress, which boasts 10 years of experience in the rare disease and is the largest and most established multistakeholder European orphan drug event; we have launched the Cell & Gene Therapy Co-Conference ! Join us for a spectacular 3 days in Barcelona, Spain from 12th–14th of November 2019.
The annual Cell & Gene therapy event for rare diseases will address the clinical, strategic and commercial aspects that are impacting the reality of gene therapy. Co-located with the World Orphan Drug Congress, the conference brings government authorities, payers, industry and patient advocacy groups all under one roof; with dedicated content and tracks on Cell & Gene Therapy Clinical Developments, Manufacturing (Scale Up & Delivery), Precision Medicine, Market Access, Pricing & Reimbursement.
Enjoy discussions on:
Cell & Gene Therapies
Clinical Trial Updates
Manufacture (Scale Up & Delivery)
Overcoming Regulatory Hurdles
Incorporating Patients into the Clinical Development Process
Pricing & Reimbursement
Pitch & Partner
Dr Josep Torrent-Farnell
Head of the medicine division